Clinical trials
Withdrawn Phase 3 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Kissei Pharmaceutical Co., Ltd. | 1 |
| Kyoto University | 1 |
| Novartis | 1 |
| Shire | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Leiomyoma | 1 |
| Lung Neoplasms | 1 |
| Multiple Myeloma | 1 |
| Panuveitis | 1 |
| Recurrence | 1 |
| Urinary Bladder, Overactive | 1 |
| Urinary Incontinence, Urge | 1 |
| Uveitis | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.